# Study of Nasonex in the Relief of Nasal Congestion in Patients With Seasonal Allergic Rhinitis (Study P05583)

> **NCT00728416** · PHASE3 · COMPLETED · sponsor: **Organon and Co** · enrollment: 333 (actual)

## Conditions studied

- Allergic Rhinitis

## Interventions

- **DRUG:** Mometasone furoate nasal spray (MFNS)
- **DRUG:** Matching placebo nasal spray

## Key facts

- **NCT ID:** NCT00728416
- **Lead sponsor:** Organon and Co
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-08
- **Primary completion:** 2008-10
- **Final completion:** 2008-10
- **Target enrollment:** 333 (ACTUAL)
- **Last updated:** 2022-02-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00728416

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00728416, "Study of Nasonex in the Relief of Nasal Congestion in Patients With Seasonal Allergic Rhinitis (Study P05583)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00728416. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*